Changes in T lymphocyte subsets predict the efficacy of atezolizumab in advanced non-small cell lung cancer: a retrospective study

por Wang, Yuyang, Zhu, Jingjuan, Zhou, Na, Wang, Yun, Zhang, Xiaochun
Publicado 2023

A Pilot Study: Favorable Effects of Clostridium butyricum on Intestinal Microbiota for Adjuvant Therapy of Lung Cancer

por Cong, Jing, Zhang, Chuantao, Zhou, Siyu, Zhu, Jingjuan, Liang, Chengwei
Publicado 2022

Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment

por Zhu, Jingjuan, Xu, Xiao, Jiang, Man, Yang, Fangfang, Mei, Yingying, Zhang, Xiaochun
Publicado 2023

ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma

por Sun, Dantong, Zhao, Han, Zhou, Hai, Tao, Junyan, Li, Tianjun, Zhu, Jingjuan, Hou, Helei
Publicado 2023

Primary resistance to first-generation EGFR-TKIs induced by MDM2 amplification in NSCLC

por Sun, Dantong, Zhu, Yan, Zhu, Jingjuan, Tao, Junyan, Wei, Xiaojuan, Wo, Yang, Hou, Helei
Publicado 2020

The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis

por Hou, Helei, Sun, Dantong, Liu, Kewei, Jiang, Man, Liu, Dong, Zhu, Jingjuan, Zhou, Na, Cong, Jing, Zhang, Xiaochun
Publicado 2019

Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification

por Sun, Dantong, Tao, Junyan, Yan, Weihua, Zhu, Jingjuan, Zhou, Hai, Sheng, Yingying, Xue, Chaofan, Li, Hong, Hou, Helei
Publicado 2022

Chemotherapy Alters the Phylogenetic Molecular Ecological Networks of Intestinal Microbial Communities

por Cong, Jing, Zhu, Jingjuan, Zhang, Chuantao, Li, Tianjun, Liu, Kewei, Liu, Dong, Zhou, Na, Jiang, Man, Hou, Helei, Zhang, Xiaochun
Publicado 2019

Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma

por Zhou, Na, Liu, Congmin, Hou, Helei, Zhang, Chuantao, Liu, Dong, Wang, Guanqun, Liu, Kewei, Zhu, Jingjuan, Lv, Hongying, Li, Tianjun, Zhang, Xiaochun
Publicado 2016

Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC

por Hou, Helei, Qin, Kang, Liang, Yu, Zhang, Chuantao, Liu, Dong, Jiang, Haiping, Liu, Kewei, Zhu, Jingjuan, Lv, Hongying, Li, Tianjun, Zhang, Xiaochun
Publicado 2019

A Pilot Study: Changes of Gut Microbiota in Post-surgery Colorectal Cancer Patients

por Cong, Jing, Zhu, Hua, Liu, Dong, Li, Tianjun, Zhang, Chuantao, Zhu, Jingjuan, Lv, Hongying, Liu, Kewei, Hao, Chenxing, Tian, Zibin, Zhang, Jianli, Zhang, Xiaochun
Publicado 2018

Anlotinib Combined with Toripalimab as Second-Line Therapy for Advanced, Relapsed Gastric or Gastroesophageal Junction Carcinoma

por Jiang, Man, Zhang, Chuantao, Hu, Yabin, Li, Tianjun, Yang, Guangjie, Wang, Guanqun, Zhu, Jingjuan, Shao, Changfeng, Hou, Helei, Zhou, Na, Liu, Kewei, Zhang, Xiaochun
Publicado 2022